top of page

U.S. FDA Approves Subcutaneous Administration of Takeda's ENTYVIO® (vedolizumab) for Maintenance Therapy in Moderately to Severely Active Ulcerative Colitis

ENTYVIO Is the Only FDA-Approved Ulcerative Colitis Biologic That Offers the Choice of Intravenous or Subcutaneous Maintenance Therapy

In the NEWS: Welcome

Metastatic Crohn's DISEASE

Metastatic Crohn's disease, defined as skin lesions present in areas noncontiguous with the gastrointestinal tract, is the rarest cutaneous manifestation of Crohn's disease. MCD lesions vary in morphology and can arise anywhere on the skin. MCD presents equally in both sexes and across age groups. ~NIH (2017)


If you feel that you are experiencing symptoms of Metastatic Crohn's Disease, please don't hesitate to reach out to me or your healthcare provider. You are not going through this alone. I was just recently diagnosed after suffering for 4yrs with no answers. You have support and there is treatment for you.

Metastatic Crohn's Disease is rare. The most common sites affected are:
It may also be found in areas where two patches of skin rub together. 
These lesions are typically plague-like in appearance, although in some cases they may look more like ulcers. They're reddish or purple in color. Metastatic lesions may appear by themselves or in groups.

In the NEWS: News and Updates
bottom of page